Alamar Biosciences(ALMR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ALMR Alamar Biosciences

Post-Mkt 09-10 17:50:08 EDT

27.77

-1.19

-4.11%

盘后27.77

+0.000.00%

16:10 EDT

High28.84	Low27.33	Vol340.00K
Open28.82	D1 Closing28.96	Amplitude5.20%
Mkt Cap1.92B	Tradable Cap359.27M	Total Shares69.31M
T/O9.43M	T/O Rate2.63%	Tradable Shares12.94M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ALMR","market":"US","secType":"STK","nameCN":"Alamar Biosciences","latestPrice":27.77,"timestamp":1789070400000,"preClose":28.96,"halted":0,"volume":339997,"hourTrading":{"tag":"盘后","latestPrice":27.77,"preClose":27.77,"latestTime":"16:10 EDT","volume":10010,"amount":277977.7,"timestamp":1789071007210,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.041091160220994516,"floatShares":12937500,"shares":69311200,"eps":-0.716,"marketStatus":"Post-Mkt","change":-1.19,"latestTime":"09-10 17:50:08 EDT","open":28.82,"high":28.835,"low":27.33,"amount":9433435,"amplitude":0.051968,"askPrice":28.31,"askSize":70,"bidPrice":27.23,"bidSize":74,"shortable":3,"etf":0,"ttmEps":-0.716,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":4,"adr":0,"listingDate":1776398400000,"exchange":"NASDAQ","adjPreClose":28.96,"preHourTrading":{"tag":"盘前","latestPrice":28.12,"preClose":28.96,"latestTime":"07:35 EDT","volume":202,"amount":5848.239966,"timestamp":1789040140809,"change":-0.84,"changeRate":-0.029006,"amplitude":0.029006},"postHourTrading":{"tag":"盘后","latestPrice":27.77,"preClose":27.77,"latestTime":"16:10 EDT","volume":10010,"amount":277977.7,"timestamp":1789071007210,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.702634},"requestUrl":"/m/hq/s/ALMR/","defaultTab":"news","newsList":[{"id":"2664014868","title":"Alamar Biosciences Director Robert P. Ragusa Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2664014868","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664014868?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:26","pubTimestamp":1788467214,"startTime":"0","endTime":"0","summary":"Alamar Biosciences director Robert P. Ragusa files initial beneficial ownership statementAlamar Biosciences director Robert P. Ragusa filed an initial Form 3 beneficial ownership statement dated Sept.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL7VLC9s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664661318","title":"Alamar Biosciences Appoints Robert Ragusa to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2664661318","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664661318?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:02","pubTimestamp":1788292941,"startTime":"0","endTime":"0","summary":"Alamar Biosciences appoints Robert Ragusa to boardAlamar Biosciences appointed Robert Ragusa to its board, effective Sept. 1, 2026.Ragusa will serve as a Class I director, with an initial term running","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL32sFr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658917839","title":"Alamar Biosciences Price Target Raised to $32.00/Share from $28.00 by Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2658917839","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658917839?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:51","pubTimestamp":1786470660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALMR/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMR","SF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658122669","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2658122669","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658122669?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:33","pubTimestamp":1786469637,"startTime":"0","endTime":"0","summary":"Quantum  swung to non-GAAP adjusted net income in fiscal Q1, while revenue exceeded the company's own guidance range, it said late Monday.Shares soared nearly 61% amid a surge in intraday trading volume to over 11.8 million from a daily average of about 1.14 million.NIQ Global Intelligence  reported Q2 adjusted earnings late Monday, swinging from a loss a year earlier. Revenue grew faster than the market had forecast.Shares surged 41% as intraday trading volume jumped to over 6.01 million from a daily average of roughly 1.57 million.Alamar Biosciences  reported a narrower Q2 net loss and sales above consensus late Monday.Shares advanced 34%, with intraday trading volume rising to more than 667,000 from the stock's daily average of about 286,000.Price: 18.65, Change: +6.87, Percent Change: +58.32","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["QMCO","BK4121","NIQ","BK4170","BK4602","ALMR","BK4009"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658912131","title":"Alamar Biosciences Stock Soars, CEO Says Company Is Well-Positioned to Sustain Upcoming Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2658912131","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658912131?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:25","pubTimestamp":1786469146,"startTime":"0","endTime":"0","summary":"Alamar Biosciences expands its Alzheimer’s data partnership, adds 86,000 samples and reports Q2 sales growth of 82% year-over-year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/earnings/26/08/61120052/alamar-biosciences-stock-soars-ceo-says-company-is-well-positioned-to-sustain-upcoming-momentum","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4150","BETZ","ODDZ","ALMR","RSI","ODDS","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658919998","title":"Alamar Biosciences up over 18%, on Track for Record High Close and Record Percent Increase","url":"https://stock-news.laohu8.com/highlight/detail?id=2658919998","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658919998?lang=en_us&edition=fundamental","pubTime":"2026-08-11 22:42","pubTimestamp":1786459320,"startTime":"0","endTime":"0","summary":"Alamar Biosciences, Inc.  is currently at $33.24, up $5.26 or 18.77%--Would be new all-time closing high --Would be largest percent increase on record --Currently up seven of the past nine days--Up 31.09% month-to-date--Would be a new 52-week closing high--Up 74.15% from its 52-week closing low of $19.09 on May 26, 2026--Traded as high as $33.59; new all-time intraday high --Up 20.01% at today's intraday high; largest intraday percent increase on record All data as of 10:40:08 AM ETSource: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMR","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658990131","title":"BofA Adjusts Price Target on Alamar Biosciences to $31 From $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2658990131","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658990131?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:13","pubTimestamp":1786450433,"startTime":"0","endTime":"0","summary":"Alamar Biosciences (ALMR) has an average rating of buy and mean price target of $33.40, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997656","title":"Alamar Biosciences price target raised to $32 from $28 at Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997656","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997656?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:42","pubTimestamp":1786448552,"startTime":"0","endTime":"0","summary":"Stifel raised the firm’s price target on Alamar Biosciences (ALMR) to $32 from $28 and keeps a Buy rating on the shares after the company posted a ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-price-target-raised-to-32-from-28-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-price-target-raised-to-32-from-28-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658998279","title":"U.S. Research Roundup-Accendra Health, Celestica, Sionna Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2658998279","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658998279?lang=en_us&edition=fundamental","pubTime":"2026-08-11 16:10","pubTimestamp":1786435846,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna TherapeuticsAug 11 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, includin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL8N4480HI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRTS","LNG","AGL","ALMR","ITA","CNC","TPYP","COGT","ABBV","CHMI","ORBX","COP","OILT","AMAT","CLBK","SECZ","AAON","BBY","BKD","CEVA","CODI","COR","ACH","RXL","AFG","BOEU","ALL","BBIO","FTXH","BWMN","ASTS","CLS","BA","AFL","IYH","AAOI","BKV","AXSM","ASTH","ANF","ASPN","ACVA","CRC","IEO","CENX","MO","IGE","APP","CON","TGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658952467","title":"Alamar Biosciences Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658952467","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658952467?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:38","pubTimestamp":1786397923,"startTime":"0","endTime":"0","summary":"Alamar Biosciences Inc reports results for the quarter ended June 30 - Earnings SummaryAlamar Biosciences IncALMR.OQreported a quarterly adjusted loss of 22 cents per share for the quarter ended June ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N44723J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658954341","title":"Alamar Biosciences Outlook FY Revenue $116 Mln-$120 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2658954341","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658954341?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:53","pubTimestamp":1786395213,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXD7W9SP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALMR","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658039951","title":"Alamar Biosciences reports Q2 EPS (22c), consensus (32c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658039951","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658039951?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:35","pubTimestamp":1786394141,"startTime":"0","endTime":"0","summary":"Reports Q2 revenue $29.4M, consensus $25.94M. “We delivered a strong second quarter with consumable revenue growing nearly 150% year-over-year,” sa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-reports-q2-eps-22c-consensus-32c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-reports-q2-eps-22c-consensus-32c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658951055","title":"Alamar Biosciences sees FY26 revenue $116M-$120M, consensus $113.22M","url":"https://stock-news.laohu8.com/highlight/detail?id=2658951055","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658951055?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:35","pubTimestamp":1786394137,"startTime":"0","endTime":"0","summary":"16:32 EDT Alamar Biosciences (ALMR) sees FY26 revenue $116M-$120M, consensus $113.22M Published first on TheFly – the ultimate source for real-time...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-sees-fy26-revenue-116m-120m-consensus-113-22m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-sees-fy26-revenue-116m-120m-consensus-113-22m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658495168","title":"Alamar Biosciences Q2 2026 Net Loss Widens to $13.2 Million; Revenue Rises 82% to $29.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658495168","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658495168?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:30","pubTimestamp":1786393805,"startTime":"0","endTime":"0","summary":"Alamar Biosciences Q2 2026 net loss widens to $13.2 million; revenue rises 82% to $29.4 millionAlamar Biosciences posted Q2 revenue of $29.4 million, up 82% year over year.Net loss widened to $13.2 mi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL7Yf7FM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658597819","title":"Earnings Flash (ALMR) Alamar Biosciences Posts Q2 Loss Per Share $0.22, vs. FactSet Est of $0.31 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658597819","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658597819?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:18","pubTimestamp":1786393122,"startTime":"0","endTime":"0","summary":"Earnings Flash (ALMR) Alamar Biosciences Posts Q2 Loss Per Share $0.22, vs. FactSet Est of $0.31 Loss","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658295919","title":"Alamar Biosciences Q2 EPS $(0.22) Beats $(0.33) Estimate, Sales $29.427M Beat $25.940M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658295919","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658295919?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:13","pubTimestamp":1786392790,"startTime":"0","endTime":"0","summary":"Alamar Biosciences Q2 EPS $(0.22) Beats $(0.33) Estimate, Sales $29.427M Beat $25.940M Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/ALMR","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Alamar Biosciences Q2 EPS $(0.22) Beats $(0.33) Estimate, Sales $29.427M Beat $25.940M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658695647","title":"Alamar Biosciences Expands Global Partnership with Alzheimer’s Disease Data Initiative and Gates Ventures","url":"https://stock-news.laohu8.com/highlight/detail?id=2658695647","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658695647?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:03","pubTimestamp":1786392180,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA4Z3MS6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657215316","title":"Alamar Biosciences Inc Expected to Post a Loss of 33 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657215316","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657215316?lang=en_us&edition=fundamental","pubTime":"2026-08-08 05:56","pubTimestamp":1786139767,"startTime":"0","endTime":"0","summary":"Alamar Biosciences Inc <ALMR.OQ> expected to post a loss of33cents a share - Earnings PreviewAlamar Biosciences IncALMR.OQALMR.Ois expected to  report resultson August 10 for the period ending June 30 2026The Fremont California-based  company is expected to report revenue of $25.94 million, according to the mean estimate from 5 analysts, based on LSEG data.LSEG's mean analyst estimate for Alamar Biosciences Inc is for a loss of 33 cents per share.The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 4 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\"The average consensus recommendation for the advanced medical equipment & technology peer group is also \"Buy\".Wall Street's median 12-month price target for Alamar Biosciences Inc is $32.00, about 13.9% above its last closing price of $28.10This summary was machine generated August 7 at 21:56 GMT.  All figures in US dollars unless otherwise stated.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4442MD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657614462","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2657614462","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657614462?lang=en_us&edition=fundamental","pubTime":"2026-08-07 18:00","pubTimestamp":1786096800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Company                                   Symbol     Quarter  Mean  Report Time. ACM Research Inc. Class A                       2Q       .42       BMO. Algonquin Power & Utilities Corp.                2Q       .03   6:30 AM. Alpha Metallurgical Resources Inc.               2Q      (.43)  7:30 AM. Construction Partners Inc. Class A              3Q      1.01       BMO. Kimbell Royalty Partners LP                      2Q       .23   7:00 AM. Park Hotels & Resorts Inc.                        2Q       .25       AMC. Plains All American Pipeline L.P.                2Q       .38   7:30 AM. Plains GP Hldgs LP Class A                      2Q       .46   7:30 AM. Rapid Micro BioSyss Inc. Class A                2Q      (.24)      BMO. Spectrum Brands Hldgs Inc.                       3Q      1.46   6:30 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATMU","ELVA","CRC","ACMR","ANAB","B","CAMT","DMAC","CIB","CODI","AXSM","ANIP","AIOT","APEI","ALMR","ACHR","CCAP","DCGO","EMBC","AMR","BBIO","CBLL","ASTS","BWMN","UA","CLMT","ACH","AMTM","AQN","CECO","ALC","BZH","CGC","DCH","CEVA","ACM","CNDT","BKD","BODI","BTDR","ELTX","EMA","ARQ","AAON","BCSF","ACVA","DH","CTEV","DCBO","CNTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178681101","title":"Earning Preview: Alamar Biosciences Q2 revenue is expected to decrease by 0.37%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1178681101","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178681101?lang=en_us&edition=fundamental","pubTime":"2026-08-03 10:30","pubTimestamp":1785724253,"startTime":"0","endTime":"0","summary":"Abstract Alamar Biosciences will report second-quarter 2026 financial results on August 10, 2026 Post-Mkt, and investors are focused on top-line durability, margin trajectory, and whether losses...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Earning Preview: Alamar Biosciences Q2 revenue is expected to decrease by 0.37%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alamarbio.com","stockEarnings":[{"period":"1week","weight":-0.0502},{"period":"1month","weight":0.0347},{"period":"3month","weight":0.3051},{"period":"6month","weight":0.7035},{"period":"ytd","weight":0.7035}],"compareEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":-0.0138},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1512},{"period":"1year","weight":0.1723},{"period":"ytd","weight":0.118}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Alamar Biosciences, Inc. was incorporated in Delaware on May 7, 2018, and is headquartered in Fremont, California. The company is a commercial-stage proteomics company dedicated to establishing the gold standard in protein detection and analysis. It offers the proprietary NULISA platform, which enables \"precision proteomics\" by detecting low-abundance protein biomarkers in non-invasive biofluids with ultra-high sensitivity, high specificity, flexible multiplexing, broad dynamic range, and automation. The company provides integrated solutions comprising instruments, consumables, and analytical software for discovery, translational research, and diagnostic development.","exchange":"NASDAQ","name":"Alamar Biosciences","nameEN":"Alamar Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Alamar Biosciences(ALMR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Alamar Biosciences(ALMR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Alamar Biosciences,ALMR,Alamar Biosciences股票,Alamar Biosciences股票老虎,Alamar Biosciences股票老虎国际,Alamar Biosciences行情,Alamar Biosciences股票行情,Alamar Biosciences股价,Alamar Biosciences股市,Alamar Biosciences股票价格,Alamar Biosciences股票交易,Alamar Biosciences股票购买,Alamar Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Alamar Biosciences(ALMR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Alamar Biosciences(ALMR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction